D'AMICO, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1426
EU - Europa 1361
AS - Asia 77
AF - Africa 2
Totale 2866
Nazione #
US - Stati Uniti d'America 1422
PL - Polonia 892
IT - Italia 180
IE - Irlanda 126
SE - Svezia 78
CN - Cina 55
FI - Finlandia 25
UA - Ucraina 24
DE - Germania 20
VN - Vietnam 16
GB - Regno Unito 11
TR - Turchia 5
CA - Canada 3
RU - Federazione Russa 2
SC - Seychelles 2
CH - Svizzera 1
EE - Estonia 1
KR - Corea 1
MX - Messico 1
NL - Olanda 1
Totale 2866
Città #
Warsaw 892
Fairfield 287
Chandler 175
Seattle 132
Dublin 126
Ashburn 125
Cambridge 116
Woodbridge 116
Houston 107
Wilmington 76
Florence 72
Beijing 53
Altamura 38
Lawrence 37
Ann Arbor 34
Jacksonville 33
Princeton 32
Boston 21
Buffalo 19
Boardman 13
Dong Ket 12
Medford 11
San Diego 7
Phoenix 6
Dearborn 5
Izmir 5
Andover 4
Milan 4
Norwalk 4
Padova 4
Bremen 3
Toronto 3
Auburn Hills 2
Incisa 2
London 2
Scandicci 2
Torino 2
Bari 1
Candiolo 1
Cardiff 1
Castelliri 1
Cedar Knolls 1
Colima 1
Dicomano 1
Falls Church 1
Figline Valdarno 1
Leawood 1
Nanjing 1
Radcliffe 1
Redwood City 1
Rome 1
San Jose 1
Totale 2597
Nome #
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression 254
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications 213
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. 210
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 208
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 206
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. 179
New concepts about fibroblasts trophic function 153
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 112
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 108
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity 101
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 100
Long-term modulation of HERG channel gating in hypoxia 87
Cell imaging and manipulation by nonlinear optical microscopy 80
Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. 77
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. 74
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer 73
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines 72
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. 72
Incorporation of the HERG potassium channel in a mercury supported lipid bilayer. 72
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 72
A metal-supported biomimetic micromembrane allowing the recording of single channel activity and of impedance spectra of membrane proteins. 66
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 64
Tethered bilayer lipid micromembranes for single channel recording: the role of adsorbed and partially fused lipid vesicles 62
Potassium channels: novel emerging biomarkers and targets for therapy in cancer. 59
Second-harmonic generation sensitivity to transmembrane potential in normal and tumor cells 55
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 44
Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias 42
Totale 2915
Categoria #
all - tutte 4010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018175 0000 00 2427 26343430
2018/2019501 18162816 4414 1618 2865130108
2019/2020837 65672858 9398 80100 80738312
2020/2021432 33441655 2135 1837 53732027
2021/2022183 56127 1212 510 1193559
2022/2023521 531333858 53108 780 0000
Totale 2915